Pathophysiology, Investigations, and Management of Atrial Septal Defect
Asian Journal of Medical Principles and Clinical Practice,
Background: ASD (atrial septal defect) is one of the most prevalent types of congenital heart disorders, affecting around one-quarter of all children. When the link between the right and left atria is not closed, an atrial septal defect arises. It includes both real septal membrane abnormalities and additional anomalies that allow communication between the two atria. From most common to least common, there are five types of atrial septal defects: patent foramen ovale, ostium secundum defect, ostium primum defect, sinus venosus defect, and coronary sinus defect. In most cases, small atrial septal abnormalities close on their own throughout development. Large lesions that do not seal on their own may require percutaneous or surgical intervention to avoid consequences like stroke, dysrhythmias, and pulmonary hypertension. This exercise covers the assessment, diagnosis, and treatment of atrial septal defect, as well as the importance of team-based interprofessional care for individuals with the condition.
Conclusion: The goal of this review article is to identify the etiology of the atrial septal defect, describe the presentation of a patient with atrial septal defect, describe the treatment and management options available for atrial septal defect, and explain interprofessional team strategies for improving care coordination and communication for patients with the atrial septal defect.
- Atrial septal defect
- congenital heart disease
- Ostium primum defect
- Ostium secundum defect
- pulmonary arterial hypertension
- sinus venosus defect.
How to Cite
Li QY, Newbury-Ecob RA, Terrett JA, et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet. 1997 Jan;15(1):21-9.
Ruiz-Perez VL, Ide SE, Strom TM, et al. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet. 2000 Mar;24(3):283-6.
Benson DW, Silberbach GM, Kavanaugh-McHugh A, et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest. 1999 Dec;104(11):1567-73.
Cao Y, Wang J, Wei C, et al. Genetic variations of NKX2-5 in sporadic atrial septal defect and ventricular septal defect in Chinese Yunnan population. Gene. 2016 Jan 1;575(1):29-33.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 2008 Dec 2;118(23):2395-451.
Kutty S, Hazeem AA, Brown K, et al. Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect. Am J Cardiol. 2012 May 1;109(9):1348-52.
Ostermayer SH, Srivastava S, Doucette JT, et al. Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications. Catheter Cardiovasc Interv. 2015 Dec 1; 86(7):1195-203.
Nishida H, Nakatsuka D, Kawano Y, Hiraiwa N, Takanashi S, Tabata M. Outcomes of totally endoscopic atrial septal defect closure using a glutaraldehyde-treated autologous pericardial patch.Circ J. 2017 Apr 25;81(5):689-93.
Kaya Y, Yurtdas M, Ceylan Y, et al. [Percutaneous closure of secundum atrial septal defects in pediatric and adult patients: short- and mid-term follow-up results] [Turkish]. Turk Kardiyol Dern Ars. 2013 Dec. 41(8):705-13.
Humenberger M, Rosenhek R, Gabriel H, et al. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J. 2011 Mar. 32(5):553-60.
Salehian O, Horlick E, Schwerzmann M, et al. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J Am Coll Cardiol. 2005 Feb 15;45(4):499-504.
Di Salvo G, Drago M, Pacileo G, et al. Atrial function after surgical and percutaneous closure of atrial septal defect: a strain rate imaging study. J Am Soc Echocardiogr. 2005 Sep. 18(9):930-3.
Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, Wu MH. Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years. Heart Vessels. 2017 Apr;32 (4): 467-3.
Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. JAm Coll Cardiol. 2004 Jan 21;43(2):302-9.
Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol. 2005 Apr 19;45(8):1213-8.
Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 2004 Dec;63(4):496-502.
Tarnok A, Bocsi J, Osmancik P, Hausler HJ, Schneider P, Dahnert I. Cardiac troponin I release after transcatheter atrial septal defect closure depends on occluder size but not on patient's age. Heart.2005 Feb;91(2):219-22.
Egred M, Andron M, Albouaini K, Alahmar A, Grainger R, Morrison WL. Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up. J Interv Cardiol. 2007 Oct;20(5):395-401.
Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart. 2003 Feb;89(2):199-204.
Goldberg JF. Long-term follow-up of "simple" lesions-atrial septal defect, ventricular septal defect, and coarctation of the aorta. Congenit Heart Dis. 2015 Sep;10(5):466-74.
Anzai H, Child J, Natterson B, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol. 2004 Feb 15. 93(4):426-31.
Argenziano M, Oz MC, DeRose JJ Jr, et al. Totally endoscopic atrial septal defect repair with robotic assistance. Heart Surg Forum. 2002;5(3):294-300.
Bartel T, Konorza T, Arjumand J, et al. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation. 2003 Feb 18l;107(6):795-7.
Bartel T, Konorza T, Neudorf U, et al. Intracardiac echocardiography: an ideal guiding tool for device closure of interatrial communications. Eur J Echocardiogr. 2005 Mar;6(2):92-6.
Benson DW, Sharkey A, Fatkin D, et al. Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects. Circulation. 1998 May 26;97(20):2043-8.
Besterman E. Atrial septal defect with pulmonary hypertension. Br Heart J. 1961 Sep;23(5):587-98.
Bialkowski J, Karwot B, Szkutnik M, Banaszak P, Kusa J, Skalski J. Closure of atrial septal defects in children: surgery versus Amplatzer device implantation. Tex Heart Inst J. 2004;31(3):220-3.
Cherian G, Uthaman CB, Durairaj M, et al. Pulmonary hypertension in isolated secundum atrial septal defect: high frequency in young patients. Am Heart J. 1983 Jun;105(6):952-7.
Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol. 2002 Mar 20;39(6):1061-5.
Holmvang G, Palacios IF, Vlahakes GJ, et al. Imaging and sizing of atrial septal defects by magnetic resonance. Circulation. 1995 Dec 15;92(12): 3473-80.
Abstract View: 28 times
PDF Download: 12 times